-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Initiates Coverage On Ocular Therapeutix with Buy Rating, Announces Price Target of $15

Benzinga·03/11/2025 10:48:06
Listen to the news
Needham analyst Serge Belanger initiates coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Buy rating and announces Price Target of $15.